Univ. Lille, CHU Lille, ULR 2694-METRICS: Évaluation des technologies de santé et des pratiques médicales, Institut Coeur Poumon, Bld Professeur J. Leclercg, F-59000, Lille, France.
INSERM CIC-IT 1403, Centre d'Investigation Clinique pour les Innovations Technologiques, Institut Coeur Poumon, Bld Professeur J. Leclercg, F-59000, Lille, France.
Int J Qual Health Care. 2021 Jan 12;33(Supplement_1):31-36. doi: 10.1093/intqhc/mzaa103.
A large proportion of the patient injuries or deaths attributable to medical device (MD) misuse can be eliminated and/or mitigated by adopting an effective human factors and ergonomics (HFE) approach. The implementation of a usability engineering process is now mandatory for MD manufacturers seeking to obtain the European Union's CE Mark. Here, we describe the European Union's HFE regulation and highlight the challenges faced by (i) manufacturers implementing this regulation and (ii) regulatory bodies charged with assessing the compliance of usability files. In Europe, 95% of MD manufacturers are small- and medium-sized enterprises; compliance with the CE Mark regulations is a real challenge to their competitiveness. Levels of knowledge about HFE vary greatly from one regulatory organization to another, which can sometimes lead to very different expectations. We also present the specific use-related risk management approach required by the HFE regulation. Lastly, we focus on the limitations of the HFE regulation for MDs and on future HFE challenges in further reducing and/or eliminating MD use errors. The main challenge is the need to go beyond technology design and the premarket assessment and to look at the postproduction stage; the coupling between an MD and a sociotechnical system can lead to consequences that were not predicted during the design process. This implies the need to consider the emerging properties of technologies in use by involving all the stakeholders.
大量可归因于医疗器械(MD)使用不当的患者伤害或死亡,可以通过采用有效的人为因素和工效学(HFE)方法来消除和/或减轻。现在,寻求获得欧盟 CE 标志的医疗器械制造商必须实施可用性工程流程。在这里,我们描述了欧盟的 HFE 法规,并强调了(i)实施该法规的制造商和(ii)负责评估可用性文件合规性的监管机构所面临的挑战。在欧洲,95%的医疗器械制造商都是中小企业;符合 CE 标志法规对他们的竞争力是一个真正的挑战。各监管机构对 HFE 的了解程度差异很大,这有时会导致期望大不相同。我们还介绍了 HFE 法规要求的特定与用途相关的风险管理方法。最后,我们重点介绍了 HFE 法规对医疗器械的局限性以及进一步减少和/或消除医疗器械使用错误的未来 HFE 挑战。主要挑战是需要超越技术设计和上市前评估,着眼于生产后期;医疗器械与社会技术系统的耦合可能会导致在设计过程中未预测到的后果。这意味着需要通过让所有利益相关者参与进来,考虑到技术在使用中出现的新特性。